Biological and environmental monitoring of occupational exposure to cyclophosphamide in industry and hospitals
- 31 March 1988
- journal article
- review article
- Published by Elsevier in Mutation Research/Genetic Toxicology
- Vol. 204 (3) , 465-479
- https://doi.org/10.1016/0165-1218(88)90042-0
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Cytokinesis-block micronucleus method in human lymphocytes: effect of in vivo ageing and low dose X-irradiationMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1986
- Urinary cyclophosphamide assay as a method for biological monitoring of occupational exposure to cyclophosphamideInternationales Archiv für Arbeitsmedizin, 1986
- Limitations of the salmonella/mammalian microsome assay (AMES test) to determine occupational exposure to cytostatic drugsEuropean Journal of Cancer and Clinical Oncology, 1986
- Cytogenetic effects of cyclophosphamide on human lymphocytes in vivo and in vitroMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1986
- Hazards to Health Workers from Antineoplastic DrugsNew England Journal of Medicine, 1985
- Sister-chromatid exchanges in lymphocytes and mutagenicity in urine of nurses handling cytostatic drugsMutation Research/Genetic Toxicology, 1985
- Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals, based on registered information of outcome.Journal of Epidemiology and Community Health, 1985
- MUTATION FREQUENCY IN NURSES AND PHARMACISTS WORKING WITH CYTOTOXIC DRUGSAustralian and New Zealand Journal of Medicine, 1984
- OCCUPATIONAL EXPOSURE TO CYCLOPHOSPHAMIDEThe Lancet, 1984
- Cytogenetic toxicity of cyclophosphamide and its metabolites in vitroCytogenetic and Genome Research, 1980